Paris - Delayed Quote EUR
Crossject Société Anonyme (ALCJ.PA)
1.0000
+0.0010
+(0.10%)
At close: May 2 at 5:35:16 PM GMT+2
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Patrick Alexandre | Co-Founder, CEO & Chairman of the Executive Board | -- | -- | -- |
| Dr. Isabelle Liebschütz | Chief Quality & Regulatory Officer and Member of Executive Board | -- | -- | -- |
| Mr. Olivier Giré | COO of Specialty Pharma & Member of Executive Board | -- | -- | -- |
| Dr. Dan Chiche M.D. | Chief Medical Officer North America | -- | -- | -- |
| Mr. Tony Tipton | Chief Operating Officer of U.S | -- | -- | -- |
Crossject Société Anonyme
- Sector:
- Healthcare
- Industry: Medical Instruments & Supplies
Description
Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, a needle-free device for patient-side management disorders self-injectables. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisis; Epinephrine for anaphylactic shock; and Sumatriptan for the treatment of migraine and cluster headaches, as well as Hydrocortisone for acute adrenal crisis and Methotrexate for the treatment of rheumatoid arthritis. The company was founded in 2001 and is based in Dijon, France.
Corporate Governance
Crossject Société Anonyme’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 27, 2025 at 6:30 AM UTC
Crossject Société Anonyme Earnings Date
Recent Events
Recent Events Information Not Available